Biochip Array Technology from Randox is capable of simultaneous multi-analyte diagnostic testing within the fields of clinical research and testing, Drugs of Abuse screening and DNA analysis.
Biochip Array Technology is an immunoassay testing platform for the simultaneous multi-analyte testing of a panel of related analytes. The technology works by combining a panel of related assays on a single biochip with a single set of reagents, controls and calibrators. Only one single undivided sample is used. The results are read by a CCD-camera and custom image-processing software.
Based on proven ELISA principles, the innovative feature of Biochip Array Technology is simultaneous multi-analyte testing. Each biochip has 25 Discrete Test Regions (DTRs) and each DTR holds an individual analyte for testing. This means that 23 tests can be carried out with two reserved for internal quality control, another unique Biochip Array Technology feature.
An extensive range of comprehensive biochip panels are available, each optimised to provide the best performance. With so much choice, you are sure to find what you need. Please view the individual arrays to find out more
Biochip Immunoassay range
Applications of Biochip Array Technology
- Research applications: Universities, contract research organisations, private/public sector research and environmental/veterinary laboratories.
- Pharma and Drug Development: Pre-clinical and clinical studies, forensic and drugs of abuse testing, molecular testing, and veterinary testing.